Corecam Pte Ltd’s Biogen BIIB Stock Holding History

Corecam Pte Ltd’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$226K	Hold	1,000	–	–	0.09%	72
2026 Q2	$216K	Buy	+1,000	New	+$191K	0.08%	75

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Corecam Pte Ltd's BIIB Position: Q3 2026 in Review

Corecam Pte Ltd held its Biogen (BIIB) position steady in Q3 2026 at 1,000 shares worth $226K. The position accounts for 0.09% of the portfolio, ranked #72.

Corecam Pte Ltd first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Corecam Pte Ltd held 1,000 shares of Biogen worth $226K as of Q3 2026.
Corecam Pte Ltd left its Biogen share count unchanged in Q3 2026.
Biogen made up 0.09% of Corecam Pte Ltd's portfolio in Q3 2026, its #72 holding.
Corecam Pte Ltd first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Corecam Pte Ltd's 13F filing for Q3 2026, filed 23 Oct 2026.